A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer

2020-07-04

عنوان الدراسة

دواء الدراسة

DOCETAXEL, Paclitaxel, TAMOXIFEN and Letrozole

رقم بروتوكول الدراسة

S1007

حالة الدراسة

Ongoing

موقع الدراسة

King Faisal Specialist Hospital and Research Center (Riyadh)

مرحلة الدراسة

An official government website affiliated with the Government of the Kingdom of Saudi Arabia.

Official Saudi government website domains end with gov.sa

Government websites use the protocol. HTTPS for encryption and security.

Registered with the Digital Government Authority under number:

Suggestions